Development and validation of a pathomics-driven machine learning model for individualized prediction of neoadjuvant chemotherapy response and early recurrence in HR-positive, HER2-negative breast cancer
开发和验证基于病理组学的机器学习模型，用于个体化预测HR阳性、HER2阴性乳腺癌新辅助化疗反应和早期复发
期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2026.1770037
Yue, Jiaxian; Liu, Jiaxiang; Kang, Xiyu; Yuan, Pei; Wang, Wei; Wang, Zhanyu; Shang, Chao; Shang, Qingyao; Li, Guangyu; Dong, Xubin; Wang, Tianxiao; Yang, Dongmin; Wang, Shuhao; Yang, Chenxuan; Ying, Jianming; Wang, Xin
